South Korea · Delayed Price · Currency is KRW METACARE CO. Statistics
Total Valuation
METACARE CO. has a market cap or net worth of KRW 29.00 billion. The enterprise value is 103.98 billion.
| Market Cap | 29.00B |
| Enterprise Value | 103.98B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
METACARE CO. has 22.05 million shares outstanding. The number of shares has increased by 7.24% in one year.
| Current Share Class | 22.05M |
| Shares Outstanding | 22.05M |
| Shares Change (YoY) | +7.24% |
| Shares Change (QoQ) | +3.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 9.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.73 |
| PB Ratio | 0.21 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | 9.14 |
| P/OCF Ratio | 7.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.72, with an EV/FCF ratio of 32.76.
| EV / Earnings | n/a |
| EV / Sales | 2.60 |
| EV / EBITDA | 21.72 |
| EV / EBIT | 58.83 |
| EV / FCF | 32.76 |
Financial Position
The company has a current ratio of 0.48, with a Debt / Equity ratio of 0.54.
| Current Ratio | 0.48 |
| Quick Ratio | 0.41 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 16.93 |
| Debt / FCF | 23.31 |
| Interest Coverage | 0.49 |
Financial Efficiency
Return on equity (ROE) is -1.42% and return on invested capital (ROIC) is 0.73%.
| Return on Equity (ROE) | -1.42% |
| Return on Assets (ROA) | 0.39% |
| Return on Invested Capital (ROIC) | 0.73% |
| Return on Capital Employed (ROCE) | 0.95% |
| Weighted Average Cost of Capital (WACC) | 4.22% |
| Revenue Per Employee | 1.29B |
| Profits Per Employee | -51.43M |
| Employee Count | 31 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 57.53 |
Taxes
| Income Tax | -69.94M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.58% in the last 52 weeks. The beta is 0.58, so METACARE CO.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -58.58% |
| 50-Day Moving Average | 1,297.12 |
| 200-Day Moving Average | 2,316.55 |
| Relative Strength Index (RSI) | 47.65 |
| Average Volume (20 Days) | 21,164 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, METACARE CO. had revenue of KRW 39.95 billion and -1.59 billion in losses. Loss per share was -92.00.
| Revenue | 39.95B |
| Gross Profit | 10.74B |
| Operating Income | 1.35B |
| Pretax Income | -1.91B |
| Net Income | -1.59B |
| EBITDA | 4.37B |
| EBIT | 1.35B |
| Loss Per Share | -92.00 |
Balance Sheet
The company has 11.24 billion in cash and 73.97 billion in debt, with a net cash position of -62.73 billion or -2,844.80 per share.
| Cash & Cash Equivalents | 11.24B |
| Total Debt | 73.97B |
| Net Cash | -62.73B |
| Net Cash Per Share | -2,844.80 |
| Equity (Book Value) | 137.68B |
| Book Value Per Share | 5,688.10 |
| Working Capital | -52.88B |
Cash Flow
In the last 12 months, operating cash flow was 3.74 billion and capital expenditures -563.33 million, giving a free cash flow of 3.17 billion.
| Operating Cash Flow | 3.74B |
| Capital Expenditures | -563.33M |
| Depreciation & Amortization | 3.02B |
| Net Borrowing | 9.73B |
| Free Cash Flow | 3.17B |
| FCF Per Share | 143.94 |
Margins
Gross margin is 26.88%, with operating and profit margins of 3.38% and -3.99%.
| Gross Margin | 26.88% |
| Operating Margin | 3.38% |
| Pretax Margin | -4.78% |
| Profit Margin | -3.99% |
| EBITDA Margin | 10.93% |
| EBIT Margin | 3.38% |
| FCF Margin | 7.94% |
Dividends & Yields
METACARE CO. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.24% |
| Shareholder Yield | -7.24% |
| Earnings Yield | -5.50% |
| FCF Yield | 10.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 24, 2026. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
METACARE CO. has an Altman Z-Score of 0.17 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.17 |
| Piotroski F-Score | 5 |